首页> 美国卫生研究院文献>Cancer Management and Research >Cancer risk assessment in modern radiotherapy workflow with medical big data
【2h】

Cancer risk assessment in modern radiotherapy workflow with medical big data

机译:具有医疗大数据的现代放射治疗工作流程中的癌症风险评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Modern radiotherapy (RT) is being enriched by big digital data and intensive technology. Multimodality image registration, intelligence-guided planning, real-time tracking, image-guided RT (IGRT), and automatic follow-up surveys are the products of the digital era. Enormous digital data are created in the process of treatment, including benefits and risks. Generally, decision making in RT tries to balance these two aspects, which is based on the archival and retrieving of data from various platforms. However, modern risk-based analysis shows that many errors that occur in radiation oncology are due to failures in workflow. These errors can lead to imbalance between benefits and risks. In addition, the exact mechanism and dose–response relationship for radiation-induced malignancy are not well understood. The cancer risk in modern RT workflow continues to be a problem. Therefore, in this review, we develop risk assessments based on our current knowledge of IGRT and provide strategies for cancer risk reduction. Artificial intelligence (AI) such as machine learning is also discussed because big data are transforming RT via AI.
机译:大数字数据和密集技术使现代放射治疗(RT)变得更加丰富。多模态图像配准,智能指导计划,实时跟踪,图像指导RT(IGRT)和自动跟进调查是数字时代的产物。在处理过程中会产生大量的数字数据,包括收益和风险。通常,RT中的决策会试图平衡这两个方面,这是基于各种平台的数据存档和检索。但是,基于风险的现代分析表明,放射肿瘤学中发生的许多错误是由于工作流程中的失败所致。这些错误可能导致收益与风险之间的不平衡。另外,对于辐射诱发的恶性肿瘤的确切机制和剂量反应关系还没有很好的了解。现代RT工作流程中的癌症风险仍然是一个问题。因此,在本次审查中,我们根据对IGRT的当前知识进行风险评估,并提供降低癌症风险的策略。还讨论了诸如机器学习之类的人工智能(AI),因为大数据正在通过AI转换RT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号